Transendocardial injections of cell-based products are being studied as a therapeutic delivery modality for patients with chronic heart failure (HF) and are generally considered to be safe. Our aim is… Click to show full abstract
Transendocardial injections of cell-based products are being studied as a therapeutic delivery modality for patients with chronic heart failure (HF) and are generally considered to be safe. Our aim is to determine the acute effects of intramyocardial injections on left ventricular (LV) function as
               
Click one of the above tabs to view related content.